Mechanism for mutational inactivation of the tumor suppressor Smad2

Molecular and Cellular Biology

Volumn 21, Issue 10, 2001, Pages 3302-3313

  Prunier, C ^a   Ferrand, N ^a   Frottier, B ^a   Pessah, M ^a   Atfi, A ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CONTROLLED STUDY; GENE INACTIVATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; MUTATION; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035034034     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.10.3302-3313.2001     Document Type: Article

References (45)

1. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling
2. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
3. Activation of a serine/threonine kinase signaling pathway by TGF-β
4. Induction of apoptosis by DPC4, a transcriptional factor regulated by TGF-β through SAPK/JNK signaling pathway
5. Evidence for a role of Rho-like GTPases SAPK/JNK in TGF-β-mediated signaling
6. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway
7. Transcriptional partner for MAD proteins in TGF-β signaling
8. Smad4 and FAST-1 in the assembly of activin-responsive factor
9. G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: Phenotypes reversed by a tumorigenic mutation
10. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
11. TGF-β receptor signaling
12. Smads: Transcriptional activators of TGF-β responses
13. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
14. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
15. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
16. TGF-β signaling from cell membrane to nucleus through SMAD proteins
17. Oncoprotein networks
18. Smad6 inhibits signaling by the TGF-β superfamily
19. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors
20. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras
21. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways
22. The L3 loop: A structural motif determining specific interactions between Smad proteins and TGF-β receptors
23. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers
24. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
25. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
26. TGF-β signal transduction
27. Controlling TGF-β signaling
28. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4
29. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signaling
30. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
31. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion
32. Frequency of Smad gene mutations in human cancers
33. The transforming growth factors-βs
34. A structural basis for mutational inactivation of the tumour suppressor Smad4
35. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling
36. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
37. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers
38. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
39. Smads and early developmental signaling by the TGF-β superfamily
40. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex
41. TGF-β signals through a heteromeric protein kinase receptor complex
42. Mechanism of activation of the TGF-β receptor
43. Structural basis of Smad2 recognition by the Smad anchor for receptor activation
44. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
45. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function